News

Weight loss drugs may lower risk of dementia, stroke

Weight loss jabs 'could lower risk of dementia', scientists find
A new study found weight loss injections may help reduce the risk of dementia and stroke in people who are obese and have type 2 diabetes
Revealed: How Popular Weight Loss Drug May Lower Dementia and Stroke Risk
Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years
Weight loss jabs linked to lower dementia and stroke risk
Weight loss jabs may offer a protective effect against dementia and stroke, according to a new study.People with type 2 diabetes and obesity who are taking the drugs are also less likely to die prematurely,
Scientists discover unexpected link between weight loss jabs and dementia
Newly published research claims those taking GLP-1 jabs are at a 37 percent lower risk of dementia than those on the anti-diabetic medication.
Study suggests weight loss jabs like Mounjaro could stop you getting dementia and other serious health problems
A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health issues like dementia
Study Finds Weight-Loss Meds May Lower Dementia, Stroke Risk
A new study of 60,000 people around the world is shedding light on the possible brain health benefits of popular weight-loss drugs like Ozempic and Wegovy, specifically for their potential to significantly lower the risk for dementia and stroke.
Ozempic ingredient linked to reduced dementia risk in diabetes patients, CWRU study shows
The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School of Medicine suggests.
Psychology Today16d
New Study: Ozempic May Lower the Risk of Alzheimer’s
Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...
The American Journal of Managed Care23d
Semaglutide Linked to Lower Dementia Risk in Type 2 Diabetes
An analysis of 1.7 million patients shows semaglutide may significantly reduce Alzheimer and vascular dementia risk compared with other diabetes drugs.
The brain busting side-effects of Ozempic-like fat jabs revealed – ‘slashing risk of silent killers’
THEY’VE been hailed as miracle weight-loss jabs – but the effects of Ozempic-style drugs could go far beyond the waistline. New research suggests these so-called “skinny pens” may also ...
Gizmodo23d
Ozempic Might Be a Dementia Buster, Too - Gizmodo
Research out today is the latest to suggest that semaglutide can significantly lower people's risk of dementia.
New York Post22d
Weight loss drugs like Ozempic may prevent dementia: study
A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could lower your risk of developing dementia.
ConsumerAffairs23d
Semaglutide may reduce dementia risk in diabetic patients
A new study suggests semaglutide may lower dementia risk in type 2 diabetes patients, particularly among women and older adults. More research needed.